German Prosthetics Firm Ottobock, Owner Seek €709 Million in IPO

German prosthetics manufacturer Ottobock SE and its controlling Näder family are seeking to raise up to €708.7 million ($831.2 million) through an initial public offering in Frankfurt, with shares priced between €62 and €66. This IPO involves the sale of both new shares from Ottobock and existing shares from the Näder family, representing a significant capital raise and liquidity event for the company and its long-standing owners.

Analysis

German prosthetics manufacturer Ottobock SE is proceeding with an initial public offering on the Frankfurt exchange, targeting a total capital raise of up to €708.7 million ($831.2 million). The offering is structured with a price range of €62 to €66 per share. A key detail of the transaction is its composition: the company itself will issue approximately 1.6 million new shares, while the controlling Näder family will sell a significantly larger block of about 9.1 million existing shares. This structure indicates the IPO serves a dual purpose: a modest capital injection for the company and a substantial liquidity event for its long-standing family shareholders, who are monetizing a portion of their stake. The offering is therefore heavily weighted towards the secondary sale of existing shares.

Key Decisions for Investors

• Investors should scrutinize the dual-purpose nature of the IPO, as the offering is dominated by the sale of existing shares by the Näder family, which warrants an assessment of their motives for seeking liquidity.
• A thorough valuation analysis is required to determine if the proposed €62-€66 price range offers an attractive entry point relative to publicly traded peers in the medical technology and healthcare sectors.
• Given the family will likely retain significant control post-IPO, it is crucial to evaluate the proposed corporate governance structure and the alignment of interests between the family and new minority shareholders.